The U.S. Securities and Exchange Commission (SEC) eventually filed its opening remedies-related brief and supporting documents in the long-running SEC v Ripple lawsuit. The federal court granted order to keep Ripple’s remedies-related discovery documents, such as detailed financial statements and post-complaint XRP institutional sales, sealed from public access. US SEC Files Remedies-Related Brief in Ripple The post Ripple XRP Case: SEC Submits Remedies-Related Brief, Here’s What Ahead appeared first on CoinGape .